Pharmacyte Biotech, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on May 5, 2021, by Pharmacyte Biotech, Inc., a Nevada corporation. The filing serves as a current report regarding the 2021 Annual Meeting of Stockholders. The company is headquartered in Laguna Hills, California.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. It is a procedural report regarding corporate governance events rather than a financial performance report.
Material Changes
No material financial changes are reported in this document. The filing announces the mailing of proxy materials to stockholders of record as of April 19, 2021, and the scheduling of the Annual Meeting.
Guidance, Outlook, and Corporate Actions
The Annual Meeting is scheduled to be held virtually on June 16, 2021, at 11:00 a.m. Pacific Daylight Time. Stockholders will vote on the following matters:
- Election of seven directors nominated by the Board of Directors for one-year terms.
- Approval of a Certificate of Amendment to the Articles of Incorporation to increase the number of authorized shares of common stock.
- Approval of the 2021 Equity Incentive Plan.
- Ratification of the appointment of Armanino LLP as the independent registered public accounting firm for the fiscal year ending April 30, 2022.
Proxy materials and the Annual Report on Form 10-K for the fiscal year ended April 30, 2020, are available via the website referenced in the Notice or upon request for printed copies.
Investor Verification Checklist
- Verify the specific details of the proposed increase in authorized common shares in the attached Proxy Statement (Exhibit 99.1).
- Review the terms of the 2021 Equity Incentive Plan to understand potential dilution impacts.
- Confirm the list of seven director nominees and their qualifications.
- Access the Form 10-K for the fiscal year ended April 30, 2020, for the most recent audited financial data, as this 8-K does not contain current financial metrics.